4 Results for "

4R-Tau

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "4R-Tau" in MCE Product Catalog:

Cat. No.: HY-174215
CAS No.: 3063511-09-8
Target:  

Tau Protein

Research Areas:  

Neurological Disease

TAU-IN-3 (Compound 2) is an orally active TAU inhibitor. TAU-IN-3 inhibits the expression of MAPT exon 10 DDPAC mutant gene in HeLa cells (IC50: 0.6 µM). TAU-IN-3 reduces the 4R/3R MAPT mRNA ratio in HeLa cells transfected with WT or DDPAC minigenes. TAU-IN-3 inhibits the insertion of endogenous MAPT exon 10 and the production of 4R tau protein in cells. TAU-IN-3 modulates tau splicing in htau mice and improves the associated behavioral phenotypes. TAU-IN-3 can be used to study neurodegenerative diseases .
loading...
    loading...
Cat. No.: HY-P991704
CAS No.: 3031519-40-8
Synonyms: PRX-005

Target:  

Tau Protein

Research Areas:  

Neurological Disease

Moponetug (PRX-005), an anti-microtubule binding region (MTBR) tau monoclonal antibody, is a humanized monoclonal tri-epitopic antibody. Moponetug binds with high affinity to the R1, R2, and R3 repeats in the MTBR region of tau, and targets both 3R and 4R tau isoforms. Moponetug can be used for the study of Alzheimer’s disease .
loading...
    loading...
Cat. No.: HY-402805A
Target:  

DYRK CDK Tau Protein

Research Areas:  

Neurological Disease

DYRK2-IN-2 hydrochloride is a selective DYRK2 inhibitor with an IC50 of 40.3 nM. DYRK2-IN-2 hydrochloride shows weaker inhibitory activity against DYRK1A (IC50 = 1842 nM), DYRK1B (IC50 = 1335 nM), DYRK4 (IC50 = 1931 nM), DYRK3 (IC50 = 112 nM) and CLK (IC50 = 540-6496 nM). DYRK2-IN-2 hydrochloride inhibits the phosphorylation of Thr212 in Tau protein. DYRK2-IN-2 hydrochloride is applicable for neuronal research .
loading...
    loading...
Cat. No.: HY-P990995A
CAS No.: 2690265-18-8
Synonyms: 7G6 Antibody; 7G6-IgG2a

Target:  

Tau Protein

Research Areas:  

Neurological Disease

Etalanetug (Mouse IgG2a) (7G6 Antibody) is a mouse monoclonal antibody targeting the HVPGG motif in the microtubule-binding domain of tau protein. Etalanetug (Mouse IgG2a) reduces the levels of insoluble tau protein in multiple brain regions and inhibits the seeding and spread of pathological tau protein. Etalanetug (Mouse IgG2a) is applicable to research related to Alzheimer's disease .
loading...
    loading...